Piloting the EAGER trial: Expectant management versus induction At 38 weeks among individuals with GEstational diabetes mellitus - a Randomized controlled trial

试行 EAGER 试验：期待治疗与诱导治疗 38 周时妊娠期糖尿病患者 - 一项随机对照试验

• 批准号: 487607
• 负责人: Walker Mark C
• 金额: $ 41.52万
• 依托单位: Ottawa Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-09-01 至 2025-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=487607&lang=en
• 关键词: Clinical Trial; Expectant Management; Gestational Diabetes Mellitus; Induction Of Labour; Pilot Study; Randomized Controlled Trial

Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with many negative maternal and infant health outcomes. Induction of labour (IOL) at term may improve outcomes for mothers and babies compared to waiting until labour begins

妊娠期糖尿病(GDM)是一种常见的妊娠并发症，与许多负面的母婴健康结局有关。与等到分娩开始时相比，足月引产(IOL)可能会改善母婴的结局